We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current VVOS market cap is 2.55M. The company's latest EPS is USD -11.3451 and P/E is -0.19.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.86M | 3.4M | 3.3M | 3.25M | 3.42M |
| Operating Income | -5.01M | -4.52M | -3.49M | -4.28M | -3.79M |
| Net Income | -1.7M | -5.53M | -2.09M | -4.26M | -3.76M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 11.39M | 13.07M | 16.89M | 16.02M | 13.8M |
| Operating Income | -10.58M | -12.04M | -19.47M | -25.03M | -17.3M |
| Net Income | -11.75M | -6.13M | -20.29M | -23.85M | -13.58M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 17.1M | 13.75M | 10.32M | 10.73M | 11.8M |
| Total Liabilities | 10.11M | 11.64M | 10.27M | 10.32M | 11.22M |
| Total Equity | 6.99M | 2.11M | 46k | 411k | 582k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.55M | 25.33M | 33.69M | 13.72M | 10.73M |
| Total Liabilities | 9.18M | 8.41M | 8.15M | 8.92M | 10.32M |
| Total Equity | -2.94M | 16.92M | 25.54M | 4.8M | 411k |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -3.54M | -6.4M | -9.2M | -11.95M | -2.52M |
| Investing | -289k | -534k | -688k | -853k | -151k |
| Financing | 7.36M | 7.36M | 7.36M | 10.92M | 3.64M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.34M | -5.68M | -15.74M | -19.59M | -11.95M |
| Investing | 86k | -120k | -2.61M | -924k | -853k |
| Financing | 4.47M | 23.54M | 24.17M | N/A | 10.92M |
| Market Cap | 2.55M |
| Price to Earnings Ratio | -0.19 |
| Price to Sales Ratio | 0.18 |
| Price to Cash Ratio | 1.55 |
| Price to Book Ratio | 6.2 |
| Dividend Yield | - |
| Shares Outstanding | 1.2M |
| Average Volume (1 week) | 38.21k |
| Average Volume (1 Month) | 36.25k |
| 52 Week Change | -84.09% |
| 52 Week High | 48.79 |
| 52 Week Low | 1.91 |
| Spread (Intraday) | 0.06 (2.71%) |
| Company Name | Vivos Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://vivos.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
